Inhaled corticosteroid therapy and risk of hospitalization with pneumonia: a population-based case-control study from Denmark

R. W. Thomsen, A. Riis, C. Andrejak, J. B. Kornum, S. Christensen, M. Nørgaard (Aalborg, Denmark)

Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Session: Aetiology and treatment of community-acquired pneumonia
Session type: E-Communication Session
Number: 3193
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. W. Thomsen, A. Riis, C. Andrejak, J. B. Kornum, S. Christensen, M. Nørgaard (Aalborg, Denmark). Inhaled corticosteroid therapy and risk of hospitalization with pneumonia: a population-based case-control study from Denmark. Eur Respir J 2009; 34: Suppl. 53, 3193

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

KOBAYASHI Makoto - 15.09.2009 09:56
Confounding from COPD
In order to reduce confounding from COPD and smoking, you could compare the risk of pneumonia in ICS users compared to LABA users. Best regards T. Ringbaek
You must Login to comment this presentation.


Related content which might interest you:
Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study
Source: Eur Respir J, 53 (6) 1801257; 10.1183/13993003.01257-2018
Year: 2019



Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006–2016
Source: Eur Respir J, 53 (4) 1802130; 10.1183/13993003.02130-2018
Year: 2019



Inhaled corticosteroid/long-acting beta-2 agonist (ICS/LABA) combination can decrease mortality of COPD patients, a nationwide population-based cohort study in Taiwan
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012

Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study
Source: Eur Respir J, 54 (5) 1900804; 10.1183/13993003.00804-2019
Year: 2019



Use of inhaled corticosteroids and the risk of osteoporosis: an international cohort study
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018

Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA)
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019


Overuse of short-acting ß2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme
Source: Eur Respir J, 55 (4) 1901872; 10.1183/13993003.01872-2019
Year: 2020



Factors related to discontinuous use of inhaled drugs in COPD patients: A population-based cohort study in Lazio (Italy)
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012


Risk for asthma following pneumonia in infancy – a nationwide register-based cohort study with family design
Source: Virtual Congress 2020 – Different aspects of paediatric viral and bacterial lung infections
Year: 2020


Influence of statin treatment on cancer mortality in COPD patients: Retrospective observational cohort study
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012

Acid-suppressive medications in the first year of life and risk of childhood asthma: a population-based birth cohort study
Source: Eur Respir J, 56 (5) 2000197; 10.1183/13993003.00197-2020
Year: 2020



Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study
Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019
Year: 2020



Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
Source: Eur Respir J, 55 (5) 2000524; 10.1183/13993003.00524-2020
Year: 2020



Trends in asthma incidence in children: a UK population-based cohort study
Source: Virtual Congress 2021 – Highlights for primary care in 2021
Year: 2021



The use of high-dose inhaled corticosteroids and add-on therapy in children in the UK: an observational study of 4332 patients
Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma
Year: 2004


High-dose inhaled corticosteroids and add-on therapy use in adults in the UK: an observational study of 22,027 patients
Source: Annual Congress 2004 - Primary care: asthma
Year: 2004


Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020
Year: 2021



Late Breaking Abstract - Inhaled corticosteroids in bronchiectasis is associated to increased morbidity, Pseudomonas colonization and mortality – a five-year prospective cohort study
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020


Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study
Source: Eur Respir J, 57 (2) 2000515; 10.1183/13993003.00515-2020
Year: 2021



Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016